MENA 2024 Recordings-Glucocorticoid Induced Hyperglycemia

Glucocorticoid Induced Hyperglycemia - Dr. Salem Beshyah_1

Video Transcription

Video Summary

The presentation focused on glucocorticoid-induced hyperglycemia, exploring its pathogenesis, management, and prevention. The speaker highlighted the growing interest in this area, reflected by an increase in related studies since 1960. The impact of glucocorticoid-induced hyperglycemia is far-reaching, affecting patients with various conditions like cancer and post-transplant scenarios, increasing risks such as cardiovascular events and infection. The pathogenesis involves increased insulin resistance and reduced insulin secretion. Risk factors include the type and dosage of glucocorticoids, patient characteristics, and underlying diseases. Management strategies depend on individual risk assessment, prior diabetes history, and current health status, with glucocorticoid-induced hyperglycemia frequently occurring postprandially. Monitoring blood glucose, especially after meals, is crucial. Management guidelines recommend Individualized glycemic targets and caution when glucocorticoids are reduced to avoid hypoglycemia. The speaker suggests metformin as a preventive measure and emphasizes the importance of individualized care plans.

Keywords

glucocorticoid-induced hyperglycemia

pathogenesis

management strategies

insulin resistance

risk factors

individualized care